Safe Sex :: Britain encourages condom-carriers, campaign on safe sex

The Government has launched a hard-hitting safe sex campaign aimed at 18 to 24-year-olds. The 4-million-pound (1 pound is about 1.9 U.S. dollars) campaign will feature a series of TV, online, print and radio advertisements showing teenagers wearing pants with slogans such as “I’ve got gonorrhea” and “I’ll give you one,” with reference to sexually transmitted infections (STIs).

Heart :: AHA to launch heart magazine – Heart Insight

Heart Insight will give readers practical advice, new treatment recommendations … and encouragement. The American Heart Association announces the launch of a new patient magazine, Heart Insight, for heart patients, their families and caregivers.

Medicare :: Prescription Drug Coverage

Millions of seniors are once again affected with the issue of Medicare Part D, with the new enrollment period for the prescription drug plan starting Wednesday and running through Dec. 31.

Health :: Cardiocerebral Resuscitation better than CPR for out-of-hospital cardiac arrest

New data show that in cases of out-of-hospital cardiac arrest, interrupting chest compressions for anything — including mouth-to-mouth ventilations — appears to be detrimental. Cardiocerebral Resuscitation, a new, chest-compression-only approach developed at the University of Arizona Sarver Heart Center, improved survival rates by 300 percent and enhances bystanders’ willingness to perform CPR.

HPV :: What does the public really know about HPV?

Human papillomaviruses (HPV) are the most common sexually transmitted infections in the United States, and certain “high risk” types have been shown to cause cervical cancer. Despite recent advances in the detection and prevention of HPV, the link between the virus and cervical cancer is not well known to the public.

Rheumatoid Arthritis :: Repeat treatment with MabThera provides continuous improvement of quality of life in RA patients

Data presented at this year’s American College of Rheumatology Congress (ACR) show that patients receiving repeat treatment with MabThera/Rituxan (rituximab) achieved continued improvement in both physical and mental aspects of quality of life measures. In addition, a higher proportion of patients achieved a significant improvement in disease symptoms with a second course of MabThera, compared to the first course they received.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack